Spectrascience New Stock Analysis
Spectrascience New is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Spectrascience New stock analysis is to determine its intrinsic value, which is an estimate of what Spectrascience New is worth, separate from its market price. There are two main types of Spectrascience New's stock analysis: fundamental analysis and technical analysis.
The Spectrascience New stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Spectrascience New's ongoing operational relationships across important fundamental and technical indicators.
Spectrascience |
Spectrascience Stock Analysis Notes
The company recorded a loss per share of 0.01. Spectrascience New had not issued any dividends in recent years. The entity had 1:100 split on the 18th of November 2003. SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California. Spectrascience operates under Medical Appliances Equipment classification in the United States and is traded on OTC Exchange. It employs 5 people. To find out more about Spectrascience New contact Michael Oliver at 858 847 0200 or learn more at https://www.spectrascience.com.Spectrascience New Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Spectrascience New's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Spectrascience New or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Spectrascience New generated a negative expected return over the last 90 days | |
| Spectrascience New has some characteristics of a very speculative penny stock | |
| Spectrascience New has high likelihood to experience some financial distress in the next 2 years | |
| Spectrascience New currently holds 6.38 M in liabilities. Spectrascience New has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Spectrascience New's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 5.15 K. Net Loss for the year was (4.47 M) with loss before overhead, payroll, taxes, and interest of (194.25 K). | |
| Spectrascience New currently holds about 27.88 K in cash with (1.51 M) of positive cash flow from operations. | |
| Spectrascience New has a frail financial position based on the latest SEC disclosures |
Spectrascience Largest EPS Surprises
Earnings surprises can significantly impact Spectrascience New's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2013-03-31 | 2012-12-31 | -0.01 | -0.02 | -0.01 | 100 | ||
2012-08-14 | 2012-06-30 | -0.02 | -0.01 | 0.01 | 50 | ||
2012-11-15 | 2012-09-30 | -0.02 | -0.0068 | 0.0132 | 66 |
Spectrascience Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 492.38 K.Spectrascience Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (14.20) | (13.49) | |
| Return On Capital Employed | 0.23 | 0.25 | |
| Return On Assets | (3.71) | (3.52) | |
| Return On Equity | 0.38 | 0.40 |
Management Efficiency
Spectrascience New has return on total asset (ROA) of (0.9247) % which means that it has lost $0.9247 on every $100 spent on assets. This is way below average. Spectrascience New's management efficiency ratios could be used to measure how well Spectrascience New manages its routine affairs as well as how well it operates its assets and liabilities. At present, Spectrascience New's Return On Equity is projected to slightly decrease based on the last few years of reporting. At present, Spectrascience New's Total Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 5.10, whereas Other Assets are forecasted to decline to about 88.4 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.02) | (0.02) | |
| Tangible Book Value Per Share | (0.02) | (0.02) | |
| Enterprise Value Over EBITDA | (3.16) | (3.01) | |
| Price Book Value Ratio | (0.13) | (0.12) | |
| Enterprise Value Multiple | (3.16) | (3.01) | |
| Price Fair Value | (0.13) | (0.12) | |
| Enterprise Value | 10 M | 9.5 M |
The operational strategies employed by Spectrascience New management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Beta (30.43) | Return On Assets (0.92) |
Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Spectrascience New, as well as the relationship between them.Spectrascience New Price Movement Analysis
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Spectrascience New middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Spectrascience New. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Spectrascience New Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Spectrascience New insiders, such as employees or executives, is commonly permitted as long as it does not rely on Spectrascience New's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Spectrascience New insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Miller Sheldon L over a month ago Acquisition by Miller Sheldon L of 100000 shares of Spectrascience New at 0.06 subject to Rule 16b-3 |
Spectrascience New Outstanding Bonds
Spectrascience New issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Spectrascience New uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Spectrascience bonds can be classified according to their maturity, which is the date when Spectrascience New has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US84762LAX38 Corp BondUS84762LAX38 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
About Spectrascience Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Spectrascience New prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Spectrascience shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Spectrascience New. By using and applying Spectrascience Stock analysis, traders can create a robust methodology for identifying Spectrascience entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (997.39) | (947.52) | |
| Operating Profit Margin | (545.79) | (518.50) | |
| Net Loss | (997.39) | (947.52) | |
| Gross Profit Margin | (43.38) | (41.21) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Spectrascience New to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Complementary Tools for Spectrascience Stock analysis
When running Spectrascience New's price analysis, check to measure Spectrascience New's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectrascience New is operating at the current time. Most of Spectrascience New's value examination focuses on studying past and present price action to predict the probability of Spectrascience New's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectrascience New's price. Additionally, you may evaluate how the addition of Spectrascience New to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |